ClawHub

Abbvie Inc

v1.0.0

US pharma company known for Humira, diversified with Skyrizi, Rinvoq, strong immunology and oncology pipelines plus large M&A activities.

⭐ 0· 40·0 current·0 all-time
by@hanxueyuan

Install

OpenClaw Prompt Flow

Install with OpenClaw

Best for remote or guided setup. Copy the exact prompt, then paste it into OpenClaw for hanxueyuan/abbvie-inc.

Previewing Install & Setup.
Prompt PreviewInstall & Setup
Install the skill "Abbvie Inc" (hanxueyuan/abbvie-inc) from ClawHub.
Skill page: https://clawhub.ai/hanxueyuan/abbvie-inc
Keep the work scoped to this skill only.
After install, inspect the skill metadata and help me finish setup.
Use only the metadata you can verify from ClawHub; do not invent missing requirements.
Ask before making any broader environment changes.

Command Line

CLI Commands

Use the direct CLI path if you want to install manually and keep every step visible.

OpenClaw CLI

Bare skill slug

openclaw skills install abbvie-inc

ClawHub CLI

Package manager switcher

npx clawhub@latest install abbvie-inc
Security Scan
VirusTotalVirusTotal
Benign
View report →
OpenClawOpenClaw
Benign
high confidence
✓
Purpose & Capability
Name, description, and SKILL.md content are aligned: the skill provides corporate and market information about AbbVie. It does not request unrelated credentials, binaries, or filesystem access.
✓
Instruction Scope
SKILL.md contains static company background, timeline, and read_when triggers (topics that cause the agent to use this content). It does not instruct the agent to read local files, environment variables, or send data to external endpoints. No scope creep observed.
✓
Install Mechanism
No install spec and no code files — instruction-only. There is nothing written to disk or fetched at install time.
✓
Credentials
The skill declares no required environment variables, credentials, or config paths. There is no unjustified access requested.
✓
Persistence & Privilege
always is false and the skill is user-invocable (normal). The skill does not request persistent elevation or modify other skills or global agent settings.
Assessment
This skill is coherent and low-risk from a security perspective: it only provides static information about AbbVie and requests no secrets or installs. However, source provenance is unknown (no homepage or author link) and the data in SKILL.md may be out of date or contain minor factual errors; verify important facts (financials, patent dates, clinical claims) against authoritative sources before using them for decisions. If you need up-to-the-minute financial, regulatory, or clinical guidance, use an official or long-established data provider instead.

Like a lobster shell, security has layers — review code before you run it.

latestvk97d68rdbyaz4gf06zsa8wj5sx85qw3r
40downloads
0stars
1versions
Updated 7h ago
v1.0.0
MIT-0
@hanxueyuan
latest
Download

AbbVie

US pharmaceutical company spun off from Abbott in 2013 — built the world's best-selling drug (Humira) and successfully diversified with Skyrci, Rinvoq, and a massive M&A pipeline.

历史时间线

  • 2013 — 从雅培（Abbott）拆分独立上市
  • 2013 — Humira年营收$11B（刚拆分时）
  • 2019 — $63B收购艾尔建（Allergan，肉毒杆菌母公司）
  • 2022 — Humira年营收峰值$20.7B（史上最畅销药物）
  • 2023 — Humira美国专利到期，生物类似药涌入
  • 2023 — Rinvoq和Skyrizi接棒（合计$15B+营收）
  • 2024 — 继续通过收购扩展肿瘤和免疫管线

商业模式

研发驱动——核心治疗领域：免疫学（Humira、Skyrizi、Rinvoq）、肿瘤学（Imbruvica、Venclexta）、美学（Allergan的肉毒杆菌和填充剂）、神经科学。后Humira时代，Skyrizi和Rinvoq是增长引擎。

护城河分析

免疫学领域深度（三个免疫药物同时进入Top 20）、Allergan的美学业务（肉毒杆菌全球第一）、强大的销售团队（全球~20,000医药代表）、并购整合能力（艾尔建收购后的协同效应）。

关键数据

年营收$54B+ (2023)，50,000+员工，Humira历史累计营收$200B+

有趣事实

  • Humira（阿达木单抗）是有史以来最畅销的药物——累计营收超过2,000亿美元，超过了世界上大多数公司的年营收。
  • AbbVie从雅培拆分时只有5,000名员工——现在已是全球前十的制药公司。

Comments

Loading comments...